Guangdong Zhongsheng Pharmaceutical Co., Ltd.
002317
Peringkat dalam Saham
#4568
Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical... Guangdong Zhongsheng Pharmaceutical Co., Ltd. is a Chinese pharmaceutical company actively involved in the entire lifecycle of drug development, from research and development to manufacturing and commercialization. Its product portfolio encompasses both traditional Chinese medicines (TCM) and modern chemical pharmaceuticals. The company's robust research and development initiatives are directed towards creating solutions for a wide array of health conditions, specifically targeting ophthalmological, cardiovascular, cerebrovascular, respiratory, digestive, diabetic, oncological, and age-related degenerative diseases. Established in 1979, the company maintains its primary operations from its headquarters in Dongguan, China.
Harga Saham
$3.89
Kapitalisasi Pasar
$3.30B
Perubahan (1 hari)
-3.14%
Perubahan (1 tahun)
43.11%
Negara
CN
Perdagangan Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Kategori
Healthcare
Riwayat pemecahan saham untuk Guangdong Zhongsheng Pharmaceutical Co., Ltd. (002317)
Saham Guangdong Zhongsheng Pharmaceutical Co., Ltd. (simbol: 002317) telah mengalami total 4 kali pemecahan saham.
Pemecahan saham terbaru terjadi pada Sep 01, 2015.
Satu lembar saham 002317 yang dibeli sebelum May 13, 2010 sekarang setara dengan 9 lembar saham 002317.
Pemecahan saham terbaru terjadi pada Sep 01, 2015.
Satu lembar saham 002317 yang dibeli sebelum May 13, 2010 sekarang setara dengan 9 lembar saham 002317.
Daftar pemecahan saham
| Tahun | Pemecahan | Kelipatan | Kelipatan Kumulatif |
|---|---|---|---|
| 2015-09-01 | 2:1 | x2 | x9 |
| 2013-03-11 | 2:1 | x2 | x4.5 |
| 2011-05-13 | 3:2 | x1.5 | x2.25 |
| 2010-05-13 | 3:2 | x1.5 | x1.5 |
Pemecahan saham untuk perusahaan sejenis atau pesaing
| Perusahaan | Jumlah pemecahan saham | Kelipatan Kumulatif | Negara |
|---|---|---|---|
| 0 | - |
DE
|
|
| 2 | x2 |
DE
|
|
| 0 | - |
JP
|
|
| 0 | - |
CH
|
|
| 5 | x119 |
IN
|
